Post-marketing surveillance of pirfenidone for idiopathic pulmonary fibrosis in Japan: Interim analysis of 973 patients

被引：0
|
作者：
Ito, Maki [1 ]
Niimi, Yuka [1 ]
Nakamura, Akihiro [1 ]
Kakutani, Shinichi [2 ]
Yoshida, Yuki [2 ]
Yoshikawa, Takayoshi [1 ]
机构：
[1] Shionogi & Co Ltd, Drug Safety Management Dept, Osaka, Japan
[2] Shionogi & Co Ltd, Biostat Dept, Osaka, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Idiopathic pulmonary fibrosis; Interstitial lung disease;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2087
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
    Hideki Kato
    Yoshitaka Miyakawa
    Yoshihiko Hidaka
    Norimitsu Inoue
    Shuichi Ito
    Shoji Kagami
    Shinya Kaname
    Masanori Matsumoto
    Masashi Mizuno
    Takahisa Matsuda
    Akihiko Shimono
    Shoichi Maruyama
    Yoshihiro Fujimura
    Masaomi Nangaku
    Hirokazu Okada
    Clinical and Experimental Nephrology, 2019, 23 : 65 - 75
  • [22] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [23] Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
    Nakamura, Shiro
    Asano, Teita
    Tsuchiya, Hiroaki
    Sugimoto, Kanami
    Imai, Yuya
    Yokoyama, Seiji
    Suzuki, Yasuo
    INTESTINAL RESEARCH, 2022, 20 (03) : 329 - +
  • [24] Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
    Shuichi Ito
    Yoshihiko Hidaka
    Norimitsu Inoue
    Shinya Kaname
    Hideki Kato
    Masanori Matsumoto
    Yoshitaka Miyakawa
    Masashi Mizuno
    Hirokazu Okada
    Akihiko Shimono
    Takahisa Matsuda
    Shoichi Maruyama
    Yoshihiro Fujimura
    Masaomi Nangaku
    Shoji Kagami
    Clinical and Experimental Nephrology, 2019, 23 : 112 - 121
  • [25] Post-marketing surveillance of erlotinib for NSCLC in Japan: Interim analyses of 3,488 patients (Pts)
    Ohe, Y.
    Fukuoka, M.
    Kudoh, S.
    Nakagawa, K.
    Johkoh, T.
    Ando, M.
    Yamazaki, N.
    Takemoto, S.
    Seki, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
    Saida T.
    Yokoyama K.
    Sato R.
    Makioka H.
    Iizuka Y.
    Hase M.
    Ling Y.
    Torii S.
    Neurology and Therapy, 2017, 6 (2) : 197 - 211
  • [27] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [28] Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance
    Kato, Hideki
    Miyakawa, Yoshitaka
    Hidaka, Yoshihiko
    Inoue, Norimitsu
    Ito, Shuichi
    Kagami, Shoji
    Kaname, Shinya
    Matsumoto, Masanori
    Mizuno, Masashi
    Matsuda, Takahisa
    Shimono, Akihiko
    Maruyama, Shoichi
    Fujimura, Yoshihiro
    Nangaku, Masaomi
    Okada, Hirokazu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (01) : 65 - 75
  • [29] Safety and effectiveness of lurasidone in the treatment of Chinese schizophrenia patients: An interim analysis of post-marketing surveillance
    Wei, Yu-Mei
    Wang, Xi-Jin
    Yang, Xiao-Dong
    Wang, Chuan-Sheng
    Wang, Li-Li
    Xu, Xiao-Ying
    Zhao, Gui-Jun
    Li, Bin
    Zhu, Dao-Min
    Wu, Qi
    Shen, Yi-Feng
    WORLD JOURNAL OF PSYCHIATRY, 2023, 13 (11): : 937 - 948
  • [30] Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance
    Ito, Shuichi
    Hidaka, Yoshihiko
    Inoue, Norimitsu
    Kaname, Shinya
    Kato, Hideki
    Matsumoto, Masanori
    Miyakawa, Yoshitaka
    Mizuno, Masashi
    Okada, Hirokazu
    Shimono, Akihiko
    Matsuda, Takahisa
    Maruyama, Shoichi
    Fujimura, Yoshihiro
    Nangaku, Masaomi
    Kagami, Shoji
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (01) : 112 - 121
12345